Swiss National Bank raised its stake in shares of Castlight Health Inc (NYSE:CSLT) by 173.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 108,350 shares of the software maker’s stock after purchasing an additional 68,700 shares during the quarter. Swiss National Bank owned about 82,276.56% of Castlight Health worth $466,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of CSLT. Voya Investment Management LLC increased its stake in Castlight Health by 25.4% during the 2nd quarter. Voya Investment Management LLC now owns 26,929 shares of the software maker’s stock valued at $112,000 after purchasing an additional 5,453 shares in the last quarter. Nationwide Fund Advisors increased its stake in Castlight Health by 49.5% during the 2nd quarter. Nationwide Fund Advisors now owns 36,418 shares of the software maker’s stock valued at $151,000 after purchasing an additional 12,061 shares in the last quarter. Stifel Financial Corp increased its stake in Castlight Health by 12.3% during the 2nd quarter. Stifel Financial Corp now owns 41,000 shares of the software maker’s stock valued at $171,000 after purchasing an additional 4,500 shares in the last quarter. UBS Asset Management Americas Inc. acquired a new position in Castlight Health during the 2nd quarter valued at approximately $193,000. Finally, Edge Wealth Management LLC increased its stake in Castlight Health by 6.5% during the 2nd quarter. Edge Wealth Management LLC now owns 50,050 shares of the software maker’s stock valued at $198,000 after purchasing an additional 3,050 shares in the last quarter. Institutional investors and hedge funds own 42.55% of the company’s stock.
Shares of Castlight Health Inc (CSLT) opened at $3.70 on Wednesday. Castlight Health Inc has a twelve month low of $3.05 and a twelve month high of $5.50. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.94 and a quick ratio of 1.94.
Castlight Health (NYSE:CSLT) last announced its quarterly earnings results on Wednesday, October 25th. The software maker reported ($0.05) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.07) by $0.02. Castlight Health had a negative net margin of 45.14% and a negative return on equity of 32.57%. The firm had revenue of $34.60 million for the quarter, compared to the consensus estimate of $34.61 million. During the same period in the prior year, the firm posted ($0.05) earnings per share. The firm’s quarterly revenue was up 35.7% compared to the same quarter last year. sell-side analysts expect that Castlight Health Inc will post -0.43 earnings per share for the current year.
A number of analysts have recently weighed in on the stock. Dougherty & Co reiterated a “buy” rating on shares of Castlight Health in a research note on Thursday, August 17th. Cantor Fitzgerald reiterated a “hold” rating and issued a $5.00 price objective on shares of Castlight Health in a research note on Wednesday, October 25th. BidaskClub lowered shares of Castlight Health from a “sell” rating to a “strong sell” rating in a research note on Thursday, November 9th. Canaccord Genuity reiterated a “buy” rating and issued a $7.00 price objective on shares of Castlight Health in a research note on Thursday, October 26th. Finally, Chardan Capital cut their price objective on shares of Castlight Health from $6.50 to $6.30 and set a “buy” rating on the stock in a research note on Thursday, October 26th. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $5.22.
In other Castlight Health news, CEO John C. Doyle sold 13,686 shares of the stock in a transaction on Friday, November 17th. The shares were sold at an average price of $3.71, for a total transaction of $50,775.06. Following the transaction, the chief executive officer now directly owns 123,705 shares of the company’s stock, valued at $458,945.55. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Mangini Siobhan Nolan sold 8,866 shares of the stock in a transaction on Friday, November 17th. The shares were sold at an average price of $3.70, for a total transaction of $32,804.20. Following the transaction, the chief financial officer now directly owns 78,561 shares in the company, valued at $290,675.70. The disclosure for this sale can be found here. Insiders have sold 22,778 shares of company stock worth $84,411 over the last three months. 24.38% of the stock is currently owned by insiders.
WARNING: This story was published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this story on another site, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this story can be viewed at https://ledgergazette.com/2017/12/06/swiss-national-bank-acquires-68700-shares-of-castlight-health-inc-cslt.html.
Castlight Health Profile
Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.
Receive News & Ratings for Castlight Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.